Virtu Financial LLC Logic Bio Therapeutics, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.29 - $0.67 $23,424 - $54,118	80,774 New	80,774 $22,000
Q2 2022 Aug 09, 2022	SELL	$0.35 - $0.74 $25,016 - $52,891	-71,475 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.61 - $2.49 $33,028 - $134,821	54,145 Added 312.44%	71,475 $49,000
Q4 2021 Feb 17, 2022	BUY	$2.2 - $4.53 $38,126 - $78,504	17,330 New	17,330 $40,000
Q2 2021 Sep 17, 2021	SELL	$4.03 - $7.57 $95,595 - $179,567	-23,721 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$6.8 - $9.16 $161,302 - $217,284	23,721 New	23,721 $173,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.